All the Cannabis News That Hits Different
This is where the real stories blaze first. From weed culture and legal highs to celeb joints and worldwide ganja gossip — we’ve got the news that actually matters to the cannabis community. No boring headlines, just the freshest updates, weirdest busts, biggest wins, and dankest stories. Light up your feed with what’s happening in the world of weed.
Key Takeaways A new Nature Communications study found measurable brain changes weeks after a single 25mg psilocybin session Researchers observed altered brain connectivity, increased brain entropy, and changes in white matter imaging markers Participants also reported improvements in emotional well-being and psychological insight Scientists say the findings are promising but still preliminary due to the…
Key Takeaways 22 monks arrested at Sri Lanka’s main airport Around 110 kg of cannabis seized Drugs hidden in specially modified luggage The group had returned from Thailand One of the largest cannabis busts at the airport A group of 22 Buddhist monks has been arrested in Sri Lanka after authorities discovered a massive cannabis…
A newer cannabis study is raising serious questions about what consumers may actually be exposed to when buying weed outside the legal market. Researchers working with Health Canada tested both licensed and illicit cannabis flower samples and found a massive gap between the two. While licensed cannabis showed a low pesticide positivity rate of just…
Key Takeaways No link found between low-level prenatal cannabis exposure and cognitive harm in teens Effects disappeared after adjusting for socioeconomic factors No clear data on dosage or product type Not applicable to heavy use Environment matters more than exposure For years, cannabis use during pregnancy has been linked to concerns about long-term harm to…
Key Takeaways The U.S. government has officially announced plans to reschedule cannabis The move would shift cannabis from Schedule I to Schedule III under federal law This marks the most significant federal cannabis reform in decades Major tax benefits for cannabis businesses are now within reach Despite the shift, cannabis remains federally controlled and not…
Key Takeaways Pre-rolls became the top-selling cannabis product in the U.S. in 2025, generating $3.6 billion in revenue Growth is driven by convenience, especially among new and casual consumers Infused pre-rolls are fueling the next wave, but raise concerns around potency and tolerance Quality can be inconsistent, with some products made from lower-grade material Rolling…
Key Takeaways Researchers in Germany discovered a fossilized leaf that may belong to one of the oldest cannabis plants ever identified The fossil was found in Saxony-Anhalt and is currently being analyzed by the Museum für Naturkunde in Berlin If confirmed, the discovery could push back the evolutionary timeline of cannabis significantly Scientists remain cautious,…
Key Takeaways Trump reportedly signed an order aimed at reducing barriers to psychedelic research Substances like LSD and psilocybin remain federally restricted Researchers have long argued that regulations slow down clinical progress Interest in psychedelics for mental health treatment continues to grow A new policy move in the United States is drawing attention across the…
Key Takeaways A 2026 PAX-funded study found vaporizing cannabis reduced measured harmful byproducts by up to 99 percent compared with joint smoke The main source of toxic compounds is combustion, not the cannabis itself The study used controlled lab conditions with a single cannabis batch and measured 16 compounds Results agree with earlier research, but…
Key Takeaways Texas has effectively banned the sale of smokable hemp products as of March 31, 2026 The move targets THCA-rich flower, a major segment of the legal hemp market Possession remains legal, but sales restrictions could push demand into gray and illicit markets Consumers are expected to bypass the ban through interstate purchases and…
President Donald Trump has signed an executive order formally directing federal agencies to remove cannabis from Schedule I of the Controlled Substances Act, initiating the final phase of a long-awaited rescheduling process. The order instructs the U.S. Attorney General to expedite and complete the reclassification of cannabis, widely expected to move the plant to Schedule…
A new peer-reviewed laboratory study has found that a combination of cannabis-derived compounds can selectively kill ovarian cancer cells while largely sparing healthy ovarian cells — a promising result that adds to a growing body of early-stage cannabis oncology research. The findings, published in Frontiers in Pharmacology, examined how CBD (cannabidiol) and THC (tetrahydrocannabinol) affect…
A prominent conservative advocacy group is pushing back against federal cannabis reform, launching a petition urging President Donald Trump to block any move to reschedule marijuana under U.S. law. The organization, CatholicVote, announced this week that it is mobilizing supporters to pressure the White House to stop efforts to move cannabis from Schedule I to…
Why the Cannabis Industry Is Nervous About Rescheduling Part Two of a Three-Part Series – read part one here. Since reports emerged that the Trump administration may move cannabis from Schedule I to Schedule III, the reaction across the cannabis industry has been anything but uniform. While some operators see rescheduling as long-overdue progress, others…
Part One of a Three-Part Series Over the past several days, reports from multiple U.S. media outlets have pointed to a potentially historic shift in federal cannabis policy. According to those reports, the Trump administration is preparing to announce that cannabis will be moved from Schedule I to Schedule III under the Controlled Substances Act,…
Get top cannabis news, legal updates, industry insights and the best deals before everyone else. Sign up today!
